BULLFROG AI HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
BULLFROG AI HOLDINGS, INC. (BFRG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $0.52 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2026-08-14
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2026-03-31 was $0.48, a 71.26% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2025-03-31 was $1.67, a 43.77% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2024-03-31 was $2.97, a 50.76% increase year-over-year.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-03-31 was $1.97.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $1.56, a 43.88% decline from fiscal 2024.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $2.78, a 11.75% decline from fiscal 2023.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $3.15.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.52 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | $0.48 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | $1.56 10-K · filed 2026-03-19 | |||
| 2025-09-30 | $1.57 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | $1.67 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | $1.67 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | $2.78 10-K · filed 2026-03-19 | |||
| 2024-09-30 | $2.83 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | $2.94 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | $2.97 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | $3.15 10-K · filed 2025-03-14 | |||
| 2023-09-30 | $3.20 10-Q · filed 2024-11-08 | |||
| 2023-06-30 | $3.26 10-Q · filed 2024-08-07 | |||
| 2023-03-31 | $1.97 10-Q · filed 2024-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |